BCL2 and osteosarcoma: Our results suggest that flavopiridol treatment is cytotoxic at the nanomolar range in all osteosarcoma cell lines analyzed and can effectively decrease the expression of several anti-apoptotic BCL-2 family members, including MCL-1.